ClinicalTrials.gg
Sign In

Developmental Dysplasia of the Hip clinical trials

The registry lists 60 studies for Developmental Dysplasia of the Hip across more than 10 countries. 18 are recruiting or about to start. 48 of them are mainly about Developmental Dysplasia of the Hip (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its narrower condition Hip Dislocation, Congenital too: 112 studies, 21 open.

Get an email when these change. Save the Developmental Dysplasia of the Hip studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
28
Not yet recruiting
11
Status unknown
8
Recruiting
6
Active, not recruiting
4
Terminated
1

Phase

Phase 4
1
Early Phase 1
1

Where

Egypt
9
China
8
Canada
6
Turkey
6
United Kingdom
3
United States
3

Who runs them

Assiut University (5) · The Hospital for Sick Children (2) · University of Bergen (2) · Yuxi Su (2) · Peking University Third Hospital (2) · Alexandria University (2) · Istituto Ortopedico Rizzoli (2) · Cairo University (2)

What is being tested here

Drugs under test in Developmental Dysplasia of the Hip studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine101
Ketamine101
Sulfur Hexafluoride101
Dexamethasone001

Coming up

0phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 6 Developmental Dysplasia of the Hip studies recruiting now, 1 (17%) set no upper age limit and 5 (83%) stop at 75 or younger. 6 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
103 (50%)3 (50%)
182 (33%)2 (33%)
301 (17%)1 (17%)
401 (17%)1 (17%)
501 (17%)1 (17%)
651 (17%)1 (17%)
751 (17%)1 (17%)
851 (17%)1 (17%)

Across all 60 studies, recruiting or not: 78% stop at 75 or younger and 75% at 65; 83% take children; 2% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Developmental Dysplasia of the Hip studies take

Of 20 interventional studies with no phase under Developmental Dysplasia of the Hip, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase28 mo13–45 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 16, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 60. Browse all 60 → or search them.